The Immune Response to Influenza Infection, Curr. Top. Microbiol. Immunol, vol.128, pp.1-54, 1986. ,
DOI : 10.1007/978-3-642-71272-2_1
Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites, J. Virol, vol.48, pp.52-60, 1983. ,
Influenza vaccine: The challenge of antigenic drift, Vaccine, vol.25, issue.39-40, pp.6852-6862, 2007. ,
DOI : 10.1016/j.vaccine.2007.07.027
Application of Electroporation in DNA Vaccination Protocols, Current Gene Therapy, vol.10, issue.4, pp.281-286, 2010. ,
DOI : 10.2174/156652310791823506
Tumour-associated antigen (TAA)-specific cytotoxic T cell (CTL) response in vitro and in a mouse model, induced by TAA-plasmids delivered by influenza virosomes, European Journal of Cancer, vol.37, issue.16, pp.2097-2103, 2001. ,
DOI : 10.1016/S0959-8049(01)00241-6
Efficient delivery of DNA to dendritic cells mediated by influenza virosomes, Vaccine, vol.22, issue.5-6, pp.735-739, 2004. ,
DOI : 10.1016/j.vaccine.2003.08.024
Virosomes for antigen and DNA delivery, Advanced Drug Delivery Reviews, vol.57, issue.3, pp.451-463, 2005. ,
DOI : 10.1016/j.addr.2004.09.005
Cellular gene transfer mediated by influenza virosomes with encapsulated plasmid DNA, Biochemical Journal, vol.405, issue.1, pp.41-49, 2007. ,
DOI : 10.1042/BJ20061756
URL : https://hal.archives-ouvertes.fr/hal-00478703
Intradermal DNA immunization of mice against influenza A virus using the novel PowderJectS system, Vaccine, vol.16, issue.4, pp.394-398, 1998. ,
DOI : 10.1016/S0264-410X(97)00202-8
High-efficiency gene transfection of macrophages by lipoplexes, International Journal of Pharmaceutics, vol.206, issue.1-2, pp.97-104, 2000. ,
DOI : 10.1016/S0378-5173(00)00531-7
Further protection against antigenic drift of influenza virus in a ferret model by DNA vaccination, Vaccine, vol.15, issue.8, pp.865-868, 1997. ,
DOI : 10.1016/S0264-410X(96)00268-X
DNA Vaccines: Progress and Challenges, The Journal of Immunology, vol.175, issue.2, pp.633-639, 2005. ,
DOI : 10.4049/jimmunol.175.2.633
Influenza Vaccines: What Do We Want and How Can We Get It?, Adv. Exp. Med. Biol, vol.780, pp.161-174, 2011. ,
DOI : 10.1007/978-1-4419-5632-3_13
Influenza virosomes as an efficient system for adjuvanted vaccine delivery, Expert Opinion on Biological Therapy, vol.62, issue.2, pp.1139-1145, 2004. ,
DOI : 10.1038/328257a0
Eleven years of Inflexal?? V???a virosomal adjuvanted influenza vaccine, Vaccine, vol.27, issue.33, pp.4381-4387, 2009. ,
DOI : 10.1016/j.vaccine.2009.05.029
Induction of Virus-Specific Cytotoxic T Lymphocytes as a Basis for the Development of Broadly Protective Influenza Vaccines, Journal of Biomedicine and Biotechnology, vol.13, issue.1, p.939860, 2011. ,
DOI : 10.1016/j.vaccine.2006.05.035
Cationic Lipid/DNA Complex-Adjuvanted Influenza A Virus Vaccination Induces Robust Cross-Protective Immunity, Journal of Virology, vol.84, issue.24, pp.12691-12702, 2010. ,
DOI : 10.1128/JVI.00769-10
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004296
A DNA Vaccine-Encoded Nucleoprotein of Influenza Virus Fails To Induce Cellular Immune Responses in a Diabetic Mouse Model, Clinical and Vaccine Immunology, vol.17, issue.4, pp.683-687, 2010. ,
DOI : 10.1128/CVI.00445-09
URL : https://hal.archives-ouvertes.fr/pasteur-00746986
Vaxfectin???-Formulated Influenza DNA Vaccines Encoding NP and M2 Viral Proteins Protect Mice against Lethal Viral Challenge, Human Vaccines, vol.3, issue.5, pp.157-164, 2007. ,
DOI : 10.4161/hv.3.5.4175
Delivery Systems for Intradermal Vaccination, Curr. Top. Microbiol. Immunol, vol.351, pp.77-112, 2011. ,
DOI : 10.1007/82_2011_123
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173582
DNA vaccines: an historical perspective and view to the future, Immunological Reviews, vol.174, issue.Suppl, pp.62-84, 2011. ,
DOI : 10.1111/j.1600-065X.2010.00980.x
Infectious entry pathway of influenza virus in a canine kidney cell line, The Journal of Cell Biology, vol.91, issue.3, pp.601-613, 1981. ,
DOI : 10.1083/jcb.91.3.601
Virosomal adjuvanted antigen delivery systems, Expert Review of Vaccines, vol.2, issue.2, pp.189-196, 2003. ,
DOI : 10.1586/14760584.2.2.189
Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell's Palsy in Switzerland, New England Journal of Medicine, vol.350, issue.9, pp.896-903, 2004. ,
DOI : 10.1056/NEJMoa030595
Influenza, The Lancet, vol.362, issue.9397, pp.1733-1745, 2003. ,
DOI : 10.1016/S0140-6736(03)14854-4
Influenza Vaccine Effectiveness in Preventing Hospitalizations and Deaths in Persons 65 Years or Older in Minnesota, New York, and Oregon: Data from 3 Health Plans, The Journal of Infectious Diseases, vol.184, issue.6, pp.665-670, 2001. ,
DOI : 10.1086/323085
Influenza: old and new threats, Nature Medicine, vol.18, issue.12s, pp.82-87, 2004. ,
DOI : 10.1016/S1286-4579(00)01351-4
Induction of Heterosubtypic Immunity to Influenza Virus by Intranasal Immunization, Journal of Virology, vol.82, issue.3, pp.1350-1359, 2008. ,
DOI : 10.1128/JVI.01615-07
Influenza vaccines: new developments, Current Opinion in Pharmacology, vol.1, issue.5, pp.491-496, 2001. ,
DOI : 10.1016/S1471-4892(01)00085-6
Gene transfer mediated by fusion protein hemagglutinin reconstituted in cationic lipid vesicles, Gene Therapy, vol.6, issue.5, pp.823-832, 1999. ,
DOI : 10.1038/sj.gt.3300919
Influenza H5 virus escape mutants: immune protection and antibody production in mice, Virus Research, vol.99, issue.2, pp.205-208, 2004. ,
DOI : 10.1016/j.virusres.2003.11.012
Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development, Virology Journal, vol.7, issue.1, p.351, 2011. ,
DOI : 10.1186/1743-422X-7-351
Functional reconstitution of influenza virus envelopes, EMBO J, vol.6, pp.2651-2659, 1987. ,
Influenza pandemic vaccines: how to ensure a low-cost, low-dose option, Nature Reviews Microbiology, vol.4, issue.8, pp.565-566, 2006. ,
DOI : 10.1038/nrmicro1482
Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice, Antiviral Research, vol.81, issue.3, pp.253-260, 2009. ,
DOI : 10.1016/j.antiviral.2008.12.009
Heterologous protection against influenza by injection of DNA encoding a viral protein, Science, vol.259, issue.5102, pp.1745-1749, 1993. ,
DOI : 10.1126/science.8456302
Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA, J. Virol, vol.72, pp.5648-5653, 1998. ,
Emergence of influenza A viruses, Philos. Trans. R. Soc. Lond. B Biol. Sci, vol.356, pp.1817-1828, 2001. ,
Mechanism of adjuvant activity of cationic liposome: Phosphorylation of a MAP kinase, ERK and induction of chemokines, Molecular Immunology, vol.44, issue.15, pp.3672-3681, 2007. ,
DOI : 10.1016/j.molimm.2007.04.009
Regulation and Phenotype of an Innate Th1 Cell: Role of Cytokines and the p38 Kinase Pathway, The Journal of Immunology, vol.171, issue.11, pp.6112-6118, 2003. ,
DOI : 10.4049/jimmunol.171.11.6112
Immunogenicity and effectiveness of virosomal adjuvanted vaccines against influenza: a brief review of their utility in the elderly population, J. Prev. Med. Hyg, vol.52, pp.116-119, 2011. ,